Literature DB >> 7001883

Implantation of bacteria from the digestive tract of man and various animals into gnotobiotic mice.

P Raibaud, R Ducluzeau, F Dubos, S Hudault, H Bewa, M C Muller.   

Abstract

Fourteen microbial strains isolated from conventional rats were inoculated into axenic rats and mice receiving identical diets. The populations of these organisms which became established in the feces of gnotobiotic adult recipient rats and mice were quite similar. The only major difference was that one strain, belonging to the genus Clostridium, disappeared from the feces of gnotobiotic mice, whereas this strain became established in gnotobiotic rats. Most of the strictly anaerobic strains were absent or present only in small numbers before weaning in young rats and mice. A clear-cut barrier effect against Salmonella typhimurium was found in adult gnotobiotic mice colonized with a complex flora derived from a conventional chicken. The microflora established in these recipient mice exerted the same barrier effect when further transferred into axenic chickens. Inoculation of feces from a human donor into adult gnotobiotic recipient mice produced colonization by several strains from the donor, whereas other strains, belonging to the genera Bifidobacterium, Lactobacillus, and Clostridium were present in the donor, but did not persist in recipient mice. In these mice, nonetheless, the colonizing human fecal flora exerted an effective barrier against a toxigenic strain of Clostridium difficile. This barrier effect spontaneously disappeared several weeks later. Administration of clindamycin to the recipient mice led to large variations in the number of viable cells of C. difficile.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001883     DOI: 10.1093/ajcn/33.11.2440

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  23 in total

1.  Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry.

Authors:  Marie Claude Barc; François Bourlioux; Lionel Rigottier-Gois; Céline Charrin-Sarnel; Claire Janoir; Hélène Boureau; Joël Doré; Anne Collignon
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

2.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

Review 3.  Rodent models to study the relationships between mammals and their bacterial inhabitants.

Authors:  Rodrigo Bibiloni
Journal:  Gut Microbes       Date:  2012-08-23

4.  Enrichment media for isolation of Clostridium difficile from faeces.

Authors:  P N Levett; G Margaritis-Bassoulis
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

5.  Household pets as a potential reservoir for Clostridium difficile infection.

Authors:  S P Borriello; P Honour; T Turner; F Barclay
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

6.  Both fidaxomicin and vancomycin inhibit outgrowth of Clostridium difficile spores.

Authors:  Charlotte A Allen; Farah Babakhani; Pam Sears; Ly Nguyen; Joseph A Sorg
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

7.  Movement and fixation of intestinal microbiota after administration of human feces to germfree mice.

Authors:  Ryoko Kibe; Mitsuo Sakamoto; Hiroshi Yokota; Hiroki Ishikawa; Yuji Aiba; Yasuhiro Koga; Yoshimi Benno
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

8.  The development and stability of the genus Bacteriodes from human gut microbiota in HFA mice model.

Authors:  Jing Yuan; Benhua Zeng; Rong Niu; Huan Tang; Wenxia Li; Zhixue Zhang; Hong Wei
Journal:  Curr Microbiol       Date:  2010-12-05       Impact factor: 2.188

9.  Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment.

Authors:  S Blanquet; J P Meunier; M Minekus; S Marol-Bonnin; M Alric
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

10.  Antibiotic residues and drug resistance in human intestinal flora.

Authors:  D E Corpet
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.